TNFα in patients with congestive heart failure

Basic Research in Cardiology

Volumn 99, Issue 1, 2004, Pages 12-17

  Ceconi, Claudio ^a   Boraso, Antonella ^a   Mele, Donato ^b   Guardigli, Raffaele ^b   Ferrari, Roberto ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Cachexia; Cytokines; Heart failure; TNF

Indexed keywords

ACUTE PHASE PROTEIN; ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; APOPROTEIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; OPSONIN; PENTRAXIN; PLACEBO; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN;

BIOLOGY; CLINICAL RESEARCH; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; HEART DISEASE; HEART STIMULATION; HUMAN; INFLAMMATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY;

CYTOKINES; HEART FAILURE, CONGESTIVE; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0345737285     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-003-0443-6     Document Type: Review

References (39)

1. Adamopoulos S, Parissis J, Karatzas D, Kroupis C, Georgiadis M, Karavolias G, Paraskevaidis J, Koniavitou K, Coats AJ, Kremastinos DT (2002) Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. J Am Coll Cardiol 39 (4): 653-663
2. Agnoletti L, Curello S, Bachetti T, Malacarne F, Gaia G, Comini L, Volterrani M, Bonetti P, Parrinello G, Cadei M, Grigolato PG, Ferrari R (1999) Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: Role of tumor necrosis factor-alpha. Circulation 100 (19): 1983-1991
3. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96: 526-534
4. Anker SD, Coats AJ (1999) Cardiac cachexia: A syndrome with impaired survival and immune and neuroendocrine activation. Chest 115 (3): 836-847
5. Anker SD, Coats AJ (2002) How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 86 (2-3): 123-130
6. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, Coats AJ (1997) Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (9058): 1050-1053
7. Aukrust P, Ueland T, Lien E, Bendtzen K, Muller F, Andreassen AK, Nordoy I, Aass H, Espevik T, Simonson S, Froland SS, Gullestad L (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83: 376-382
8. Berry C, Clark A (2000) Catabolism in chronic heart failure. Eur Heart J 21: 521-532
9. Blum A, Miller H (2001) Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 52: 15-27
10. Bozkurt B, Kribbs SB, Clubb FJ Jr, Michael LH, Didenko V, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97 (14): 1382-1391
11. Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL (2001) Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 103 (8): 1044-1047
12. Bradham WS, Moe G, Wendt KA, Scott AA, Konig A, Romanova M, Naik G, Spinale FG (2002) TNF-alpha and myocardial matrix metalloproteinases in heart failure: Relationship to LV remodeling. Am J Physiol Heart Circ Physiol 282 (4): H1288-H1295
13. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B (1998) Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 97 (14): 1375-1381
14. Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35 (3): 537-544
15. Chien KR, Olson EN (2002) Converging pathways and principles in heart development and disease: CV@CSH. Cell 110: 153-162
16. Chin BS, Chung NA, Gibbs CR, Blam AD, Lip GY (2002) Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure. Am J Cardiol 90 (11): 1258-1260
17. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT; Anti-TNF therapy against congestive heart failure investigators (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107 (25): 3133-3140
18. Dörge H, Schulz R, Belosjorow S, Post H, Van De Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G (2002) Coronary microembolization: The role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol 34 (1): 51-62
19. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92 (6): 1479-1486
20. Hunter JJ, Chien KR (1999) Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341 (17): 1276-1283
21. Kadokami T, Frye C, Lemster B, Wagner CL, Feldman AM, McTiernan CF (2001) Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model. Circulation 104 (10): 1094-1097
22. Kapadia SR (1999) Cytokines and heart failure. Cardiol Rev 7 (4): 196-206
23. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL (1997) Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res 81 (2): 187-195
24. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel NJ, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 (15): 1098-1104
25. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Comstock KL, Glembotski CC, Quintana PJ, Sabbadini RA (1996) Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98 (12): 2854-2865
26. Krum H (2002) Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): Unsuccessful, to be specific. J Card Fail 8 (6): 365-368
27. Kubota T, Bounoutas GS, Miyagishima M, Kadokami T, Sanders VJ, Bruton C, Robbins PD, McTiernan CF, Feldman AM (2000) Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101 (21): 2518-2525
28. Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138 (10): 807-811
29. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (4): 236-241
30. Li YY, Feng T, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM (2000) Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor α can be modulated by anti-tumor necrosis factor α therapy. PNAS 97: 12746-12751
31. Mann DL (2002) Inflammatory mediators and the failing heart: Past, present, and the foreseeable future. Circ Res 91 (11): 988-998
32. Mann DL (2002) Tumor necrosis factor-induced signal transduction and left ventricular remodeling. J Card Fail 8 (6 Suppl): S379-S386
33. Meldrum DR (1998) Tumor necrosis factor in the heart. Am J Physiol 274 (3 Pt 2): R577-R595
34. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 353 (9167): 1838-1842
35. Parissis J, Filippatos G, Nikolaou V, Adamopoulos S (2002) Cytokines and anticytokine therapeutic approaches to chronic heart failure. Eur J Intern Med 13 (6): 356
36. Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102 (25): 3060-3067
37. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 27: 1201-1206
38. Torre-Amione G, Kapadia S, Lee J, Durand J-B, Bies RD, Young JB, Mann DL (1996) Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93: 704-711
39. Torre-Amione G, Stetson SJ, Youker KA, Durand JB, Radovancevic B, Delgado RM, Frazier OH, Entman ML, Noon GP (1999) Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation 100 (11): 1189-1193